LV13289B - Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis - Google Patents

Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis Download PDF

Info

Publication number
LV13289B
LV13289B LVP-04-102A LV040102A LV13289B LV 13289 B LV13289 B LV 13289B LV 040102 A LV040102 A LV 040102A LV 13289 B LV13289 B LV 13289B
Authority
LV
Latvia
Prior art keywords
oligopeptide
metastasis
invasion
cancer
sequences
Prior art date
Application number
LVP-04-102A
Other languages
English (en)
Latvian (lv)
Inventor
Matthias Rath
Aleksandra Niedzwiecki
Shrirang Netke
Original Assignee
Matthias Rath
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matthias Rath filed Critical Matthias Rath
Publication of LV13289B publication Critical patent/LV13289B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • C12N9/6491—Matrix metalloproteases [MMP's], e.g. interstitial collagenase (3.4.24.7); Stromelysins (3.4.24.17; 3.2.1.22); Matrilysin (3.4.24.23)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
LVP-04-102A 2002-01-23 2004-09-17 Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis LV13289B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35131702P 2002-01-23 2002-01-23

Publications (1)

Publication Number Publication Date
LV13289B true LV13289B (en) 2005-11-20

Family

ID=27613485

Family Applications (2)

Application Number Title Priority Date Filing Date
LVP-04-102A LV13289B (en) 2002-01-23 2004-09-17 Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis
LVP-05-134A LV13419B (en) 2002-01-23 2005-10-17 Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis

Family Applications After (1)

Application Number Title Priority Date Filing Date
LVP-05-134A LV13419B (en) 2002-01-23 2005-10-17 Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis

Country Status (22)

Country Link
US (1) US8012935B2 (pt)
EP (1) EP1468085B1 (pt)
JP (1) JP2005515262A (pt)
KR (1) KR20040077764A (pt)
CN (2) CN1622992A (pt)
AT (1) ATE425247T1 (pt)
BR (1) BR0302819A (pt)
CA (1) CA2472775A1 (pt)
DE (1) DE60326539D1 (pt)
EE (1) EE200400030A (pt)
ES (1) ES2324027T3 (pt)
HR (1) HRP20040732A2 (pt)
IL (1) IL162714A0 (pt)
LV (2) LV13289B (pt)
MX (1) MXPA04007170A (pt)
NO (1) NO20034146L (pt)
NZ (1) NZ533738A (pt)
PL (1) PL209827B1 (pt)
RU (1) RU2346043C2 (pt)
WO (1) WO2003062413A1 (pt)
YU (1) YU76403A (pt)
ZA (1) ZA200405328B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2856598B1 (fr) * 2003-06-25 2005-10-28 Inst Nat Sante Rech Med Peptides derives de la proteine mmp-2 et leur utilisation en immunotherapie antitumorale
JP4911950B2 (ja) * 2005-11-07 2012-04-04 晃 伊東 Ｍｍｐ−１の部分ペプチドを用いた癌浸潤・転移阻害薬
CA2754635C (en) * 2009-03-06 2018-06-19 Universite Paris Descartes Use of gingival fibroblast conditioned media to treat metastatic cancer
US8593732B1 (en) * 2010-01-23 2013-11-26 Lightsmyth Technologies, Inc. Partially metallized total internal reflection immersion grating
US8003110B1 (en) * 2011-01-24 2011-08-23 Matthias W. Rath Metalloproteinase oligopeptides and their therapeutic use
EP2649985A1 (en) * 2012-04-13 2013-10-16 Lipotec, S.A. Compounds which inhibit neuronal exocytosis (III)
US20140017267A1 (en) * 2012-07-13 2014-01-16 Matthias W Rath Metalloproteinase oligopeptides and their therapeutic use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5280106A (en) 1988-05-20 1994-01-18 Liotta Lance A Matrix metalloproteinase peptides: role in diagnosis and therapy
GB8817075D0 (en) * 1988-07-18 1988-08-24 Raychem Ltd Oscillation suppressor
US5646027A (en) * 1994-09-08 1997-07-08 Warner-Lambert Company Process for the production of gelatinase catalytic domain protein
WO2001031019A2 (en) 1999-10-29 2001-05-03 Chiron Spa Neisserial antigenic peptides

Also Published As

Publication number Publication date
ATE425247T1 (de) 2009-03-15
EE200400030A (et) 2004-04-15
RU2346043C2 (ru) 2009-02-10
KR20040077764A (ko) 2004-09-06
PL371254A1 (en) 2005-06-13
JP2005515262A (ja) 2005-05-26
WO2003062413A1 (en) 2003-07-31
ZA200405328B (en) 2006-03-29
EP1468085B1 (en) 2009-03-11
US8012935B2 (en) 2011-09-06
CN101007844A (zh) 2007-08-01
BR0302819A (pt) 2004-04-27
NZ533738A (en) 2006-03-31
NO20034146D0 (no) 2003-09-17
LV13419B (en) 2006-09-20
NO20034146L (no) 2003-10-28
YU76403A (sh) 2006-05-25
CA2472775A1 (en) 2003-07-31
DE60326539D1 (de) 2009-04-23
EP1468085A1 (en) 2004-10-20
ES2324027T3 (es) 2009-07-29
US20030139345A1 (en) 2003-07-24
HRP20040732A2 (en) 2005-06-30
RU2004125599A (ru) 2005-07-10
MXPA04007170A (es) 2004-10-29
IL162714A0 (en) 2005-11-20
CN1622992A (zh) 2005-06-01
PL209827B1 (pl) 2011-10-31

Similar Documents

Publication Publication Date Title
JP4846799B2 (ja) 腫瘍の治療
US7635682B2 (en) Tumor activated prodrugs
US7192929B2 (en) Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
LV13419B (en) Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis
US7374898B2 (en) Peptide inhibitors against seprase
AU2014346051A1 (en) Use of IL-22 dimers in manufacture of medicaments for treating pancreatitis
CN103097405B (zh) 用于伤口愈合的新型肽
US20230158100A1 (en) Treatment of panx1 associates diseases
EP3233110B1 (en) Cyclic acetylcholinesterase c-terminal peptide in the treatment or prevention of cancer or metastasis
AU2003205658A1 (en) Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis
JP2019522046A (ja) 変形性関節症の治療のためのペプチド
ZA200104130B (en) Inhibition of angiogenesis by high molecular weight kininogen and peptide analogs thereof.
LT5328B (lt) Sintetiniai peptidai ir jų panaudojimas vėžio invazijos ir metastazių gydymui ir profilaktikai
EP2507266A2 (en) TREATMENT OF IgE-MEDIATED DISEASE
WO2024031022A2 (en) Peptide compositions and methods of use
JPH08183740A (ja) 細胞接着阻害剤及び該阻害剤を含む抗炎症剤